Table 2 Characterization of valvular function by transthoracic echocardiography among 174 adults receiving therapy for hyperprolactinemia
Valve location | Valvular Thickening N (%) | Valvular Regurgitation N (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
None | Mild | >Mild | Inconclusive | 0 | 1 | 2 | 3 | 4 | |
Aortic | 155 (89.1) | 19 (10.9) | 0 | 0 | 14 (8.1) | 154 (88.5) | 6 (3.5) | 0 | 0 |
Mitral | 157 (90.2) | 17 (9.8) | 0 | 0 | 3 (1.7) | 164 (94.3) | 6 (3.5) | 1 (0.6) | 0 |
Pulmonic | 150 (86.2) | 1 (0.6) | 0 | 23 (13.2) | 15 (8.6) | 133 (76.4) | 26 (14.9) | 0 | 0 |
Tricuspid | 174 (100.0) | 0 | 0 | 0 | 12 (6.9) | 136 (78.2) | 26 (14.9) | 0 | 0 |